Icon	Function
💬	A pop-up explanation appears when you mouse-over the text beside this icon. Also, an explanation window appears when you click this icon.
	The links beside this icon are links to external sites.
	Clicking this icon sorts the table by the item with this icon (Numerical or alphabetical order). Each click toggles between ascending and descending order.
	A text longer than 100 characters is fully displayed or collapsed.
	The contents of the displayed table are downloaded as a file named "table.csv".

DR info

Clinical trials : 20 / Drugs : 19 - (DrugBank : 8) / Drug target genes : 11 - Drug target pathways : 20

Drugs, Primary sponsors and Trial info (Enrollment year, Phase, Trial ID, Countries)

AJ201
   AnnJi Pharmaceutical Co., Ltd.
      2023   Phase 1/Phase 2   NCT05517603   United States
BVS857
   Novartis Farma SpA
      2014   Phase 2   EUCTR2013-002608-15-IT   Denmark;Germany;Italy;United States
   Novartis Pharma Services AG
      2014   Phase 2   EUCTR2013-002608-15-DK   Denmark;Germany;Italy;United States
      2014   Phase 2   EUCTR2013-002608-15-DE   Denmark;Germany;Italy;United States
   Novartis Pharmaceuticals
      2014   Phase 2   NCT02024932   Denmark;Germany;Italy;United States
Clenbuterol
   AZIENDA OSPEDALIERA DI PADOVA
      2010   -   EUCTR2010-022558-18-IT   Italy
   Gianni Soraru
      2024   Phase 2   NCT06169046   Italy
Clenbuterolo
   AZIENDA OSPEDALIERA DI PADOVA
      2021   Phase 2   EUCTR2017-005103-27-IT   Italy
Creatine
   Department of Neurology, Nagoya University Graduate School of Medicine
      2014   -   JPRN-UMIN000012503   Japan
Dutasteride
   National Institute of Neurological Disorders and Stroke (NINDS)
      2006   Phase 2   NCT00303446   United States
Electrophysiologic study
   Ramathibodi Hospital
      2008   Phase 4   NCT00851461   Thailand
Goserelin
   Ramathibodi Hospital
      2008   Phase 4   NCT00851461   Thailand
Leuprolide
   National Center for Research Resources (NCRR)
      1992   Phase 2   NCT00004771   -
Leuprorelin acetate
   Department of Neurology Chiba University Graduate School of Medicine
      2008   -   JPRN-UMIN000001455   Japan
   Department of Neurology, Nagoya University School of Medicine
      2003   Phase 2   JPRN-UMIN000000474   Japan
   TAKEDA PHARMACEUTICAL COMPANY LTD.
      2017   -   JPRN-jRCT1080223924   none
   Takeda
      2017   -   NCT03555578   Japan
Mexiletine hydrochloride
   Katsuno Masahisa
      2025   Phase 2-3   JPRN-jRCT2041240174   -
   Masahisa Katsuno
      2025   Phase 2/Phase 3   NCT06862596   Japan
   Nagoya University Graduate School of Medicine
      2017   Phase 2   JPRN-UMIN000026150   Japan
Monores 20 MCG 30 compresse
   AZIENDA OSPEDALIERA DI PADOVA
      2021   Phase 2   EUCTR2017-005103-27-IT   Italy
Monores*30CPR 20MCG
   AZIENDA OSPEDALIERA DI PADOVA
      2010   -   EUCTR2010-022558-18-IT   Italy
NIDO-361
   Nido Biosciences, Inc.
      2024   Phase 2   NCT06411912   Denmark;Italy;South Korea;United Kingdom
Testosterone
   National Center for Research Resources (NCRR)
      1992   Phase 2   NCT00004771   -
Tissue biopsy
   Ramathibodi Hospital
      2008   Phase 4   NCT00851461   Thailand